Katerina V Gurova

Cleveland Biolabs, Inc.

$3,308,871

Attributed

$3,308,871

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $630.5K · FY2015–25

$1M$750K$500K$250K$0

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$3,308,871 · 4

By mechanism

R01$2,788,997 · 2

R21$419,884 · 1

R41$99,990 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Cancer Therapy”

David Heimbrook · Leidos Biomedical Research, Inc.$366,127,178
Norman Wolmark · Nsabp Foundation, Inc.$292,963,206
Gregory H Reaman · National Childhood Cancer Foundation$271,061,526
Peter C Adamson · National Childhood Cancer Foundation$269,808,480
Charles A Coltman · Southwest Oncology Group$178,303,465
Sudhir Raju · Ctis, Inc.$162,436,462

Research focus

Cancer TherapyChromatinTumorAntineoplastic AgentsMalignant NeoplasmsCellsPropertyToxic EffectLeadNeoplastic CellResponseGenetic TranscriptionSmall MoleculeChromatin Remodeling FactorMediatingDna DamageMolecular ChaperonesNormal CellInterferonsIn VivoGeneticInterferon Type ICancer CellComplex